BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7168926)

  • 1. Levonantradol effectiveness in cancer patients resistant to conventional anti-emetics.
    Kenny JB; Wilkinson PM
    Clin Oncol; 1982 Dec; 8(4):335-9. PubMed ID: 7168926
    [No Abstract]   [Full Text] [Related]  

  • 2. Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
    Stuart-Harris RC; Mooney CA; Smith IE
    Clin Oncol; 1983 Jun; 9(2):143-6. PubMed ID: 6309451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine.
    Sheidler VR; Ettinger DS; Diasio RB; Enterline JP; Brown MD
    J Clin Pharmacol; 1984 Apr; 24(4):155-9. PubMed ID: 6373843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of refractory cytostatic agent-induced vomiting with the synthetic cannabinoid levonantradol].
    Heim ME; Queisser W
    Onkologie; 1982 Apr; 5(2):94-6. PubMed ID: 7048169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levonantradol as an antiemetic in cancer chemotherapy].
    Mella O; Følling Elgjo R; Isaksen H; Klepp O
    Tidsskr Nor Laegeforen; 1984 Nov; 104(33):2320-2. PubMed ID: 6523465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Levonantradol in the treatment of nausea and vomiting caused by cytostatic drugs (author's transl) clinical studies].
    Higi M; Niederle N; Bremer K; Schmitt G; Schmidt CG; Seeber S
    Dtsch Med Wochenschr; 1982 Aug; 107(33):1232-4. PubMed ID: 7049655
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral levonantradol in the treatment of chemotherapy-induced emesis: preliminary observations.
    Diasio RB; Ettinger DS; Satterwhite BE
    J Clin Pharmacol; 1981; 21(S1):81S-85S. PubMed ID: 7298876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonantradol for the treatment of chemotherapy-induced nausea and vomiting.
    Gerhartz HH; Binsack T; Hiller E
    Klin Wochenschr; 1983 Jul; 61(14):719-21. PubMed ID: 6350696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonantradol for chemotherapy-induced emesis: phase I-II oral administration.
    Laszlo J; Lucas VS; Hanson DC; Cronin CM; Sallan SE
    J Clin Pharmacol; 1981; 21(S1):51S-56S. PubMed ID: 7298875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Models, projects of health participation].
    Scurti V; Sichetti D; Valerio M
    Assist Inferm Ric; 2005; 24(4):204-8. PubMed ID: 16550700
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy.
    Cronin CM; Sallan SE; Gelber R; Lucas VS; Laszlo J
    J Clin Pharmacol; 1981; 21(S1):43S-50S. PubMed ID: 7028793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis.
    Stambaugh JE; McAdams J; Vreeland F
    J Clin Pharmacol; 1984; 24(11-12):480-5. PubMed ID: 6392353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous levomepromazine rescue (SLR) for high grade delayed chemotherapy-induced emesis (DCIE).
    McCabe HL; Maraveyas A
    Anticancer Res; 2003; 23(6D):5209-12. PubMed ID: 14981991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of diazepam on delayed nausea and vomiting caused by anticancer agents].
    Tong FZ; Zhang JQ; Qiao XM; Mao YC; Meng FY; Liu HJ; Hui S; Zhu FX; Shu W; Hong J
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):391-5. PubMed ID: 9492833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 trial of levonantradol in chemotherapy-induced emesis.
    Tyson LB; Gralla RJ; Clark RA; Kris MG; Bordin LA; Bosl GJ
    Am J Clin Oncol; 1985 Dec; 8(6):528-32. PubMed ID: 4083271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of 2 mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
    Takada M; Furuse K; Fukuoka M; Kawahara M; Negoro S; Kusunoki Y; Ogawara M; Furue H
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):987-94. PubMed ID: 9212809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting.
    Lucraft HH; Palmer MK
    Clin Radiol; 1982 Nov; 33(6):621-2. PubMed ID: 6754212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy.
    Hutcheon AW; Palmer JB; Soukop M; Cunningham D; McArdle C; Welsh J; Stuart F; Sangster G; Kaye S; Charlton D
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1087-90. PubMed ID: 6352278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Granisetron, a antiemetic for treatment of cytostatic drug-induced vomiting: results of a practice-oriented study].
    Golaszewski T; Kölbl H; Lahousen M; Staab HJ
    Wien Klin Wochenschr; 1995; 107(20):613-21. PubMed ID: 7502509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of 2-mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
    Yoshiya N; Kodama S; Aoki Y; Takahashi T; Honma S; Endo M; Tokunaga A; Takeuchi Y; Hanaoka J; Maruhashi T; Oshima T; Tanaka K; Furue H
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1141-7. PubMed ID: 9239168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.